Company intelligence / Profile preview

EANM Research

Austria

Ownership: Private
Development stage: Commercial

Overview

EANM Research Ltd (EARL) is a subsidiary or affiliated entity of the European Association of Nuclear Medicine. It provides accreditation, standardization, and harmonization services for PET/CT scanners in clinical trials and routine practice. Its work underpins reliable quantitative molecular imaging in oncology and other fields by ensuring cross-center comparability of data through standardized protocols. There are no clinical results as it does not develop therapeutics.

Therapeutic areas: OtherOncology
Modalities: N/A (Standardization Body)
Industry: Academic Hospital/University/Research

Partnerships

Siemens HealthineersGE HealthcarePhilipsacademic centers across Europe

Beyond the preview

Go deeper on EANM Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EANM Research.

Explore the full profile